1996
DOI: 10.1007/s004670050146
|View full text |Cite
|
Sign up to set email alerts
|

Safety and cost effectiveness of pediatric percutaneous renal biopsy

Abstract: Because of the rising cost of health care, more patients are undergoing procedures as outpatients rather than inpatients. The purpose of this study was to compare safety and cost of outpatient versus inpatient, overnight stay, for children undergoing percutaneous renal biopsy. Charts of all such patients between January 1989 through January 1995 were reviewed for the following: age of patient, native versus allograft biopsy and preparation costs (in 1995 U.S. dollars), and complications. Of the 75 biopsies rev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
45
1

Year Published

2000
2000
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(48 citation statements)
references
References 4 publications
2
45
1
Order By: Relevance
“…The complication rates in different series may be as low as 2.6% or as high as 43% (9)(10)(11)(12)(13)(14)(15). In our biopsy series, the success and complication rates did not differ from most of the studies on children.…”
Section: Discussionmentioning
confidence: 49%
“…The complication rates in different series may be as low as 2.6% or as high as 43% (9)(10)(11)(12)(13)(14)(15). In our biopsy series, the success and complication rates did not differ from most of the studies on children.…”
Section: Discussionmentioning
confidence: 49%
“…The number of complications reported in children following renal biopsy varied between 0-30% for major complications [13][14][15]. In some studies, macroscopic hematuria (4.5%) was the most frequent complication for native and transplant kidney.…”
Section: Discussionmentioning
confidence: 99%
“…Payors must develop adequate compensation mechanisms in order to encourage more patient focused ambulatory care. The cost effectiveness of ambulatory care has been documented among other disease models [18][19][20][21]. A randomized study published in 1988 of inpatient versus outpatient continuous infusion chemotherapy for adult patients with locally advanced head and neck cancer demonstrated the cost-effectiveness of outpatient chemotherapy [21].…”
Section: Discussionmentioning
confidence: 99%